Hurteau JA - Search Results

1

Regulation of apoptosis in normal and malignant ovarian epithelial cells by transforming growth factor beta.

Havrilesky LJ, Hurteau JA, Whitaker RS, Elbendary A, Wu S, Rodriguez GC, Bast RC Jr, Berchuck A. Havrilesky LJ, et al. Among authors: hurteau ja. Cancer Res. 1995 Feb 15;55(4):944-8. Cancer Res. 1995. PMID: 7531618

2

Transforming growth factor-beta inhibits proliferation of human ovarian cancer cells obtained from ascites.

Hurteau J, Rodriguez GC, Whitaker RS, Shah S, Mills G, Bast RC, Berchuck A. Hurteau J, et al. Cancer. 1994 Jul 1;74(1):93-9. doi: 10.1002/1097-0142(19940701)74:1<93::aid-cncr2820740117>3.0.co;2-p. Cancer. 1994. PMID: 8004589

3

The biology of ovarian cancer.

Boente MP, Hurteau J, Rodriguez GC, Bast RC Jr, Berchuck A. Boente MP, et al. Curr Opin Oncol. 1993 Sep;5(5):900-7. doi: 10.1097/00001622-199309000-00020. Curr Opin Oncol. 1993. PMID: 8218503 Review.

4

Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta.

Rodriguez GC, Haisley C, Hurteau J, Moser TL, Whitaker R, Bast RC Jr, Stack MS. Rodriguez GC, et al. Gynecol Oncol. 2001 Feb;80(2):245-53. doi: 10.1006/gyno.2000.6042. Gynecol Oncol. 2001. PMID: 11161867

5

Chemotherapy-induced apoptosis in epithelial ovarian cancers.

Havrilesky LJ, Elbendary A, Hurteau JA, Whitaker RS, Rodriguez GC, Berchuck A. Havrilesky LJ, et al. Among authors: hurteau ja. Obstet Gynecol. 1995 Jun;85(6):1007-10. doi: 10.1016/0029-7844(95)00058-y. Obstet Gynecol. 1995. PMID: 7770245

6

Effects of omega-3 fatty acids on components of the transforming growth factor beta-1 pathway: implication for dietary modification and prevention in ovarian cancer.

Sharma A, Belna J, Espat J, Rodriguez G, Cannon VT, Hurteau JA. Sharma A, et al. Among authors: hurteau ja. Am J Obstet Gynecol. 2009 May;200(5):516.e1-6. doi: 10.1016/j.ajog.2008.12.023. Epub 2009 Mar 9. Am J Obstet Gynecol. 2009. PMID: 19268879

7

Surgery for advanced ovarian cancer.

Clarke-Pearson DL, Kohler MF, Hurteau JA, Elbendary A. Clarke-Pearson DL, et al. Among authors: hurteau ja. Clin Obstet Gynecol. 1994 Jun;37(2):439-60. doi: 10.1097/00003081-199406000-00019. Clin Obstet Gynecol. 1994. PMID: 7518370 Review. No abstract available.

8

Overexpression of the tyrosine phosphatase PTP1B is associated with human ovarian carcinomas.

Wiener JR, Hurteau JA, Kerns BJ, Whitaker RS, Conaway MR, Berchuck A, Bast RC Jr. Wiener JR, et al. Among authors: hurteau ja. Am J Obstet Gynecol. 1994 Apr;170(4):1177-83. doi: 10.1016/s0002-9378(94)70118-0. Am J Obstet Gynecol. 1994. PMID: 8166206

9

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB. Hurteau JA, et al. Cancer. 1995 Nov 1;76(9):1615-20. doi: 10.1002/1097-0142(19951101)76:9<1615::aid-cncr2820760918>3.0.co;2-g. Cancer. 1995. PMID: 8635066 Clinical Trial.

10

Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1.

Hurteau JA, Allison B, Sutton GP, Moore DH, Look KY, Hurd W, Bigsby RM. Hurteau JA, et al. Cancer. 1999 Apr 15;85(8):1810-5. doi: 10.1002/(sici)1097-0142(19990415)85:8<1810::aid-cncr22>3.0.co;2-e. Cancer. 1999. PMID: 10223576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters